• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Star Equity Holdings Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure

    8/22/25 8:48:06 AM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $STRR alert in real time by email
    8-K
    false 0000707388 0000707388 2025-08-22 2025-08-22 0000707388 us-gaap:CommonStockMember 2025-08-22 2025-08-22 0000707388 us-gaap:SeriesAPreferredStockMember 2025-08-22 2025-08-22
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported):

    August 22, 2025

     

     

    Star Equity Holdings, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-35947   33-0145723
    (State or other jurisdiction
    of incorporation)
      (Commission
    File Number)
      (IRS Employer
    Identification No.)

    53 Forest Ave, Suite 101

    Old Greenwich, CT 06870

    (Address of principal executive offices, including zip code)

    (203) 489-9500

    (Registrant’s telephone number, including area code)

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange
    on which registered

    Common Stock, par value $0.0001 per share   STRR   NASDAQ Global Market
    Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share   STRRP   NASDAQ Global Market
    Series C Participating Preferred Stock, par value $0.0001 per share Purchase Rights    

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§232.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 2.01.

    Completion of an Acquisition or Disposition of Assets.

    On August 22, 2025, Hudson Global, Inc. (“Hudson”), completed its previously announced acquisition of Star Equity Holdings, Inc. (“Star”), pursuant to the Agreement and Plan of Merger, dated as of May 21, 2025 (the “Merger Agreement”), by and among Hudson, Star and HSON Merger Sub, Inc., a wholly owned subsidiary of Hudson (“Merger Sub”). Upon the terms and subject to the conditions of the Merger Agreement, on August 22, 2025, at the effective time of the Merger (the “Effective Time”), Merger Sub will merge with and into Star, with Star continuing as the surviving corporation of the Merger under the name “Star Operating Companies, Inc.” as a wholly owned subsidiary of Hudson. Capitalized terms used herein but not defined have the meanings set forth in the Merger Agreement.

    Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each share of common stock of Star issued and outstanding immediately prior to the Effective Time (other than certain shares as set forth in the Merger Agreement) were automatically converted into the right to receive 0.23 shares of Hudson common stock and (ii) each share of preferred stock of Star issued and outstanding immediately prior to the Effective Time (other than certain shares set forth in the Merger Agreement) were automatically converted into the right to receive one (1) share of Hudson Series A preferred stock. As a result of the Merger, former Star common stockholders will receive approximately 744,291 shares of Hudson common stock for their Star common shares and former Star stockholders will receive approximately 2,690,637 shares of Hudson Series A preferred stock. No fractional shares of Hudson common stock were issued in the Merger, and Star stockholders became entitled to receive cash in lieu of fractional shares in accordance with the Merger Agreement

    In addition, pursuant to the terms of the Merger Agreement, at the Effective Time, each award of Star restricted stock units (“RSUs”) outstanding immediately prior to the Effective Time was converted into Hudson RSUs issued under the Hudson Global, Inc. 2009 Incentive Stock and Awards Plan, as amended (the “Plan”), in accordance with the Merger Agreement.

    As disclosed in greater detail in the joint proxy statement/prospectus filed with the SEC on July 23, 2025 (the “Joint Proxy Statement/Prospectus”) and distributed to the stockholders of both Hudson and Star, Jeffrey Eberwein, Hudson’s Chief Executive Officer and the holder of approximately 10% of Hudson’s common stock, is also a director and substantial stockholder of Star.

    The foregoing description of the Merger Agreement and the transactions contemplated thereby in this Current Report on Form 8-K is only a summary and does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which is filed as Exhibit 2.1 hereto and incorporated by reference herein.

     

    Item 3.01.

    Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

    On August 22, 2025, Star notified Nasdaq that the Merger had been completed and requested that Nasdaq (i) suspend trading of Star’s Common Stock and Preferred Stock on Nasdaq effective as of the open of business on August 22, 2025, (ii) withdraw Star’s Common Stock and Preferred Stock from listing on the Nasdaq Global Market and (iii) file with the Securities and Exchange Commission (the “SEC”) a notification of delisting and deregistration of Star’s Common Stock and Preferred Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

    Additionally, Star intends to file with the SEC certifications on Form 15 under the Exchange Act requesting the deregistration of Star’s Common Stock and Preferred Stock and the suspension of Star’s reporting obligations under Section 13 and Section 15(d) of the Exchange Act as promptly as practicable.


    The information set forth under Item 2.01 of this Report is incorporated by reference into this Item 3.01.

     

    Item 3.03.

    Material Modification to Rights of Security Holders.

    At the Effective Time, stockholders of Star immediately prior to the completion of the Merger ceased to have any rights as stockholders of Star other than the right to receive the Merger Consideration in accordance with the Merger Agreement, and any previously authorized yet unpaid dividends.

    The information set forth in Item 2.01 and Item 3.01 of this Report is incorporated herein by reference.

     

    Item 5.01.

    Changes in Control of Registrant.

    The information set forth in Item 2.01 and Item 3.01 of this Report is incorporated herein by reference.

     

    Item 5.02.

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On August 22, 2025, effective upon the Effective Time, Star’s directors and officers offered their resignations for serving in such capacities, at the request of Hudson and not because of any disagreement with Star regarding any matter related to Star’s operations, policies or practices.

     

    Item 7.01.

    Regulation FD Disclosure.

    On August 22, 2025, Hudson and Star issued a joint press release announcing the closing of the Merger. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference, except that the information contained on the websites referenced in the press release is not incorporated herein by reference.

    The information in this Item 7.01, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such filing.

     

    Item 9.01.

    Financial Statements and Exhibits.

     

    (d)

    Exhibits.

     

    Exhibit
    Number

      

    Title

    2.1    Agreement and Plan of Merger, dated May 21, 2025 (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed with the SEC on May 22, 2025).
    99.1    Joint Press Release, issued on August 22, 2025.
    104    Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

     

    *

    Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Star agrees to furnish supplementally to the SEC a copy of any omitted schedule upon request by the SEC.

     

    3


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: August 22, 2025   STAR EQUITY HOLDINGS, INC.
            By:  

    /s/ Richard K. Coleman, Jr.

          Richard K. Coleman, Jr.
          Chief Executive Officer
    Get the next $STRR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STRR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $STRR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President - KBS Butcher Thatcher returned 7,345 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    8/22/25 4:24:39 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Executive Chairman Eberwein Jeffrey E. returned 820,374 shares to the company and returned 1,182,414 units of 10% Series A Cumulative Perpetual Preferred Stock to the company, closing all direct ownership in the company (SEC Form 4)

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    8/22/25 4:23:30 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chief Executive Officer Coleman Richard Kenneth Jr. returned 44,233 shares to the company and returned 2,500 units of 10% Series A Cumulative Perpetual Preferred Stock to the company, closing all direct ownership in the company (SEC Form 4)

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    8/22/25 4:22:15 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Coleman Richard Kenneth Jr. bought $10,675 worth of shares (2,500 units at $4.27) and bought $4,925 worth of 10% Series A Cumulative Perpetual Preferred Stock (500 units at $9.85), decreasing direct ownership by 93% to 2,500 units (SEC Form 4)

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    8/20/24 4:10:35 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Butcher Thatcher bought $3,120 worth of shares (3,000 units at $1.04), increasing direct ownership by 100% to 6,000 units (SEC Form 4)

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    12/15/23 1:41:36 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Coleman Richard Kenneth Jr. bought $2,220 worth of shares (2,000 units at $1.11) and bought $18,900 worth of 10% Series A Cumulative Perpetual Preferred Stock (2,000 units at $9.45), decreasing direct ownership by 98% to 2,000 units (SEC Form 4)

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    12/4/23 8:25:38 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    SEC Filings

    View All

    Star Equity Holdings Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure

    8-K - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

    8/22/25 8:48:06 AM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 8-K filed by Star Equity Holdings Inc.

    8-K - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

    8/21/25 4:16:21 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Star Equity Holdings Inc. filed SEC Form 8-K: Other Events

    8-K - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

    8/15/25 4:10:33 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hudson Global and Star Equity Holdings Announce Closing of Merger

    – Combined Company Well Positioned to Leverage its Increased Size, Diversified Revenue Streams, and Improved Profitability – OLD GREENWICH, Conn., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (NASDAQ:HSON) ("Hudson Global" or "the Company"), a leading global total talent solutions company, and Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star"), a diversified holding company, announced today the completion of their previously announced merger ("the Merger"), forming a larger, diversified holding company. Both companies received stockholder approval to complete the Merger at their respective stockholders' meetings held on August 21, 2025. The common stock of Hudson Global w

    8/22/25 8:30:07 AM ET
    $HSON
    $STRR
    Professional Services
    Consumer Discretionary
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Star Equity Holdings, Inc. Announces 2025 Second Quarter Financial Results

    Q2 2025 revenues increased ~76% to $23.7 million and gross profit increased ~182% to $6.3 million Generated Adjusted EBITDA of $7.0 million Quarter-end Building Solutions backlog stands at $25.7 million OLD GREENWICH, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, reported today its financial results for the second quarter (Q2) ended June 30, 2025. All 2025 and 2024 amounts in this release are unaudited. Q2 2025 Financial Highlights vs. Q2 2024 (unaudited) Revenues increased by 75.8% to $23.7 million from $13.5 million.Gross profit increased by 182.2% to $6.3 million from $2.2 million.

    8/13/25 8:30:29 AM ET
    $HSON
    $STRR
    Professional Services
    Consumer Discretionary
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Star Equity Holdings, Inc. Declares a Partial Cash Dividend of $0.225 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

    OLD GREENWICH, Conn., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, announced today that its Board of Directors declared a partial cash dividend to holders of the Company's 10% Series A Cumulative Perpetual Preferred Stock ("Star Preferred Stock") of $0.225 per share. The record date for this dividend is August 21, 2025 and the payment date is September 10, 2025. As previously disclosed, on May 21, 2025, Hudson Global, Inc., a Delaware corporation ("Hudson"), HSON Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Hudson ("Merger Sub"), and the Company, entered into

    8/8/25 5:15:31 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    Leadership Updates

    Live Leadership Updates

    View All

    Star Equity Holdings, Inc. Appoints Rick Coleman as CEO

    OLD GREENWICH, Conn., April 01, 2022 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified holding company, announced today the appointment of Richard ("Rick") K. Coleman, Jr. as Chief Executive Officer, effective April 1, 2022. In addition, Mr. Coleman will be nominated to serve as a director at the Company's upcoming annual meeting of shareholders. Mr. Coleman is a seasoned executive who brings to Star Equity extensive CEO leadership and board-level experience with numerous public and private companies. He was appointed as Star Equity's Chief Operating Officer in January 2022 and has provided valuable insights and direction

    4/1/22 8:00:00 AM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Star Equity Holdings, Inc. Adds Richard Coleman as Chief Operating Officer

    OLD GREENWICH, Conn., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified holding company, announced today the appointment of Richard K. Coleman, Jr. ("Rick") as Chief Operating Officer, effective January 1, 2022. Coleman's addition increases the capacity of Star Equity's senior leadership team. In this role, he will oversee the Company's operations, assist its business leaders in achieving their growth and profitability goals, launch new business initiatives, as well as help analyze and integrate future acquisitions. Coleman brings more than 30 years of executive leadership experience with extensive expertis

    12/20/21 8:00:00 AM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Star Equity Holdings, Inc. Appoints John Gildea to its Board of Directors

    OLD GREENWICH, Conn., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified, multi-industry holding company with three business divisions, Healthcare, Construction, and Investments, announced today the appointment of John W. Gildea to its Board of Directors, effective immediately. Mr. Gildea's appointment as independent director expands Star Equity's Board to six members. Mr. Gildea will also serve on the Audit Committee. Mr. Gildea brings over three decades of experience investing in special situation debt and equity of small to middle market companies. He is the founding partner of Gildea Management Co., a fir

    8/6/21 4:38:13 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    Financials

    Live finance-specific insights

    View All

    Star Equity Holdings, Inc. Announces 2025 Second Quarter Financial Results

    Q2 2025 revenues increased ~76% to $23.7 million and gross profit increased ~182% to $6.3 million Generated Adjusted EBITDA of $7.0 million Quarter-end Building Solutions backlog stands at $25.7 million OLD GREENWICH, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, reported today its financial results for the second quarter (Q2) ended June 30, 2025. All 2025 and 2024 amounts in this release are unaudited. Q2 2025 Financial Highlights vs. Q2 2024 (unaudited) Revenues increased by 75.8% to $23.7 million from $13.5 million.Gross profit increased by 182.2% to $6.3 million from $2.2 million.

    8/13/25 8:30:29 AM ET
    $HSON
    $STRR
    Professional Services
    Consumer Discretionary
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Hudson Global Reports 2025 Second Quarter Results

    OLD GREENWICH, Conn., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (NASDAQ:HSON) ("Hudson Global" or "the Company"), a leading global total talent solutions company, announced today financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Summary Revenue of $35.5 million decreased 0.5% from the second quarter of 2024 and 0.2% in constant currency.Adjusted net revenue of $18.6 million increased 5.8% from the second quarter of 2024 and 5.1% in constant currency.Net loss was $0.7 million, or $0.23 per diluted share, compared to net loss of $0.4 million, or $0.15 per diluted share, for the second quarter of 2024. Adjusted net income per d

    8/8/25 8:30:45 AM ET
    $HSON
    $STRR
    Professional Services
    Consumer Discretionary
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Star Equity Holdings to Release Second Quarter 2025 Financial Results on August 13

    OLD GREENWICH, Conn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)), ("Star Equity" or the "Company"), a diversified holding company, announced today that it will release its financial results for the second quarter ended June 30, 2025, before the market opens on Wednesday, August 13, 2025. A conference call is scheduled for 10:00 a.m. ET (7:00 a.m. PT) on August 13, 2025, to discuss the results and management's outlook. The call may be accessed by dialing: Toll Free: 1-833-630-1956International: 1-412-317-1837 A simultaneous webcast of the call may be accessed online from the Events & Presentations link, on the Investor Relations page of the Star Eq

    8/4/25 8:30:30 AM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Star Equity Holdings Inc.

    SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

    9/10/24 4:04:39 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13D/A filed by Star Equity Holdings Inc. (Amendment)

    SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

    9/18/23 4:05:02 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13D/A filed by Star Equity Holdings Inc. (Amendment)

    SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

    8/31/23 5:18:25 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care